ITX5061
产品说明书
 |
同义名 : | - |
| CAS号 : | 1252679-52-9 | |
| 货号 : | A886240 | |
| 分子式 : | C30H38ClN3O7S | |
| 纯度 : | 99%+ | |
| 分子量 : | 620.16 | |
| MDL号 : | MFCD30532738 | |
| 存储条件： |
Pure form Inert atmosphere, 2-8°C In solvent -20°C:3-6个月-80°C:12个月 |
|
| 溶解度 : | - | |
| 动物实验配方： |
| 生物活性 | |||
|---|---|---|---|
| 描述 | ITX5061 is a type II inhibitor of p38 MAPK and also an antagonist of scavenger receptor B1 (SR-B1). | ||
| 临床研究 | |||||
|---|---|---|---|---|---|
| NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
| NCT01165359 | Hepatitis C | Phase 1 | Completed | - | United States, Alabama ... 展开 >> Alabama Therapeutics CRS Birmingham, Alabama, United States, 35294-2050 United States, California UCLA CARE Center CRS Los Angeles, California, United States, 90035 Ucsd, Avrc Crs San Diego, California, United States, 92103 Ucsf Aids Crs San Francisco, California, United States, 94110 United States, Maryland Johns Hopkins Adult AIDS CRS Baltimore, Maryland, United States United States, New York Univ. of Rochester ACTG CRS Rochester, New York, United States, 14642 United States, North Carolina Duke Univ. Med. Ctr. Adult CRS Durham, North Carolina, United States, 27710 United States, Ohio Univ. of Cincinnati CRS Cincinnati, Ohio, United States, 45267-0405 United States, Pennsylvania Hosp. of the Univ. of Pennsylvania CRS Philadelphia, Pennsylvania, United States, 19104 Puerto Rico Puerto Rico-AIDS CRS San Juan, Puerto Rico, 00935 收起 << |
| NCT01560468 | Hepatitis C Infection | Phase 1 | Terminated(Financial Reasons) | - | United States, New York ... 展开 >> Mount Sinai School of Medicine New York, New York, United States, 10029 收起 << |
| NCT01292824 | Hepatitis C E... 展开 >>vidence of Liver Transplantation 收起 << | Phase 1 | Completed | - | United Kingdom ... 展开 >> University Hospital Birmingham Birmingham, West Midlands, United Kingdom, B15 2TH 收起 << |
| 实验方案 | |||
|---|---|---|---|
| 1mg | 5mg | 10mg | |
|
1 mM 5 mM 10 mM |
1.61mL 0.32mL 0.16mL |
8.06mL 1.61mL 0.81mL |
16.12mL 3.22mL 1.61mL |
| 参考文献 |
|---|